"So, we've told you...we'll tell you what we know and don't know. So there's different types of tests which get sent out. The CDC's test that CDC is sending out, that's that 70...enough to send out 75,000 people, that was sent out last week. Those go to public health labs, about 80 labs in the United States, one in each state at least. Those report results back in to the CDC because they're part of the public health network. The larger quantity of tests that shipped, about 900,000 of the tests that shipped by this weekend, and then so many of the remainder of that 2 point...total, 2.1 million tests...those go to hospitals, private labs, others for testing...they don't currently have to report to us that they've conducted a test or what the result of that test is. The CDC is actively working right now to build that IT connectivity with them so we can gather that information. So right now...I could not give you a number of how many Americans have received a test because many will have received a test through hospitals or non-public health labs, and so...let's work with getting the system, the IT system up through the CDC, you want to get the accurate information as we go.
I read with great interest your Op-Ed piece in yesterday's Washington Post extolling the virtues of "Short-Term, Limited Duration" plans and how awesome it is that the Trump Administration is hoping to flood the individual health insurance market with them. I figured you might appreciate a bit of fact-checking.
Obamacare forgot about you. But Trump didn’t.
For all the discussion of Obamacare since its passage, it is too rarely known that the law effectively split the United States’ individual insurance market in two.
Yes and no. What split the market in two was the fact that premiums have increased faster than expected. Those earning more than 400% of the Federal Poverty Level (FPL)--around $48,000/year for a single adult or $98,000/year for a family of four--don't qualify for financial assistance and have to pay full price.